Showing results (11-20 of 186) with videos related to
Sort By:
Pageof 19
Acta Neurologica Scandinavica|March 1, 1976
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trialJ GerlachL'Encephale|September 1, 1988
Tardive dyskinesia. Pathophysiological mechanisms and clinical trialsJ GerlachPsychopharmacology|March 16, 1977
Relationship between tardive dyskinesia, L-Dopa-induced hyperkinesia and parkinsonismJ GerlachInternational Clinical Psychopharmacology|January 1, 1995
Depot neuroleptics in relapse prevention: advantages and disadvantagesJ GerlachCanadian Journal of Occupational Therapy. Revue Canadienne D'Ergotherapie|October 27, 2015
Sharpening our critical edge: Occupational therapy in the context of marginalized populationsAlison J GerlachCanadian Journal of Occupational Therapy. Revue Canadienne D'Ergotherapie|July 25, 2012
A critical reflection on the concept of cultural safetyAlison J GerlachDer Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 7, 2018
[Therapeutic strategies for joint infections]U-J GerlachBiological Psychiatry|October 16, 2001
Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actionsL Peacock, J GerlachJournal of Psychopharmacology (Oxford, England)|February 1, 2012
Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivityJ Gerlach, L HansenPsychopharmacology|August 6, 1999
New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effectsL Peacock, J GerlachPageof 19